Chonlaphat Sukasem Selected Research

Cytochrome P-450 CYP2B6 (CYP2B6)

1/2022	Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.
1/2014	CYP2B6 18492T->C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype 1/1.
2/2013	Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
1/2013	High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections.
12/2012	Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chonlaphat Sukasem Research Topics

Disease

22	Cicatrix (Scar) 01/2022 - 01/2014
21	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2014
19	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2022 - 01/2016
16	Autism Spectrum Disorder 01/2022 - 01/2015
10	Drug Hypersensitivity Syndrome 12/2021 - 01/2016
10	Infections 01/2021 - 03/2008
9	Hypersensitivity (Allergy) 01/2022 - 01/2014
6	Drug Hypersensitivity (Drug Allergy) 10/2021 - 01/2014
5	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2015
5	Neutropenia 01/2022 - 02/2016
5	Hyperprolactinemia 01/2022 - 01/2015
5	Eosinophilia 11/2021 - 05/2016
5	Exanthema (Rash) 07/2021 - 01/2015
5	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
4	Autistic Disorder (Autism) 01/2021 - 01/2015
3	Acute Generalized Exanthematous Pustulosis 11/2021 - 01/2019
3	Psychotic Disorders (Schizoaffective Disorder) 09/2021 - 04/2018
3	Type 2 Diabetes Mellitus (MODY) 04/2021 - 08/2017
3	Genetic Predisposition to Disease (Genetic Predisposition) 04/2021 - 01/2015
3	Insulin Resistance 01/2021 - 08/2017
3	Invasive Fungal Infections 12/2020 - 04/2016
3	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 02/2016
3	Body Weight (Weight, Body) 07/2018 - 02/2013
3	Human Influenza (Influenza) 05/2011 - 10/2008
2	Neoplasms (Cancer) 01/2022 - 01/2013
2	Obesity 09/2021 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2021 - 01/2020
2	Hyperuricemia 01/2021 - 01/2016
2	Leprosy (Hansen's Disease) 01/2021 - 12/2017
2	Influenza in Birds (Avian Flu) 01/2017 - 10/2008
2	Lipodystrophy 01/2015 - 10/2013
2	Tuberculosis (Tuberculoses) 01/2014 - 02/2013
1	Acute Coronary Syndrome 01/2022
1	Hemorrhage 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022

Drug/Important Bio-Agent (IBA)

37	Pharmaceutical PreparationsIBA 01/2022 - 03/2012
22	HLA-B Antigens (HLA-B)IBA 01/2022 - 01/2014
19	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 01/2015
11	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2022 - 01/2012
11	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022 - 01/2014
10	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2015
8	Phenytoin (Dilantin)FDA LinkGeneric 01/2022 - 05/2016
8	EnzymesIBA 01/2022 - 01/2016
7	Cytochrome P-450 CYP2C9IBA 01/2022 - 05/2016
7	efavirenz (Sustiva)FDA Link 01/2022 - 12/2012
7	Allopurinol (Remid)FDA LinkGeneric 01/2021 - 01/2014
6	Cytochrome P-450 CYP2C19IBA 01/2022 - 01/2013
5	LipidsIBA 01/2022 - 10/2013
5	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022 - 12/2012
5	Cytochrome P-450 CYP3AIBA 01/2021 - 01/2013
5	ProlactinIBA 01/2021 - 01/2016
5	Tamoxifen FDA LinkGeneric 01/2016 - 01/2012
4	Genetic Markers (Genetic Marker)IBA 01/2022 - 07/2017
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 02/2016
4	Antipsychotic Agents (Antipsychotics)IBA 09/2021 - 01/2016
4	Paliperidone Palmitate FDA Link 01/2017 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2013
3	Anticonvulsants (Antiepileptic Drugs)IBA 12/2021 - 01/2019
3	Oxcarbazepine (Trileptal)FDA LinkGeneric 12/2021 - 01/2017
3	Dapsone FDA Link 10/2021 - 12/2017
3	HLA-A Antigens (HLA-A)IBA 01/2021 - 01/2017
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021 - 11/2020
3	Voriconazole (Vfend)FDA LinkGeneric 12/2020 - 04/2016
3	LeptinIBA 01/2019 - 08/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2012
2	Oseltamivir (Tamiflu)FDA Link 01/2022 - 05/2011
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2022 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	Nevirapine (Viramune)FDA Link 01/2022 - 06/2014
2	Lamotrigine (Lamictal)FDA LinkGeneric 12/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2021
2	SulfonamidesIBA 01/2021 - 01/2019
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 01/2019
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021 - 04/2016
2	2-mercaptopurineIBA 01/2021 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2013
2	HLA-A31 antigenIBA 01/2020 - 01/2018
2	Reverse Transcriptase InhibitorsIBA 10/2019 - 04/2010
2	Leptin ReceptorsIBA 01/2019 - 04/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 08/2017
2	Insulin (Novolin)FDA Link 07/2018 - 08/2017
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 11/2008
2	Tenofovir (Viread)FDA Link 01/2015 - 01/2013
2	abacavir (Ziagen)FDA Link 01/2015 - 06/2014
2	ApolipoproteinsIBA 01/2015 - 10/2013
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	andrographolideIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	Lopinavir FDA Link 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Ivermectin (Mectizan)FDA Link 01/2022

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2008
4	Precision Medicine 01/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 10/2020 - 01/2015
2	Duration of Therapy 01/2021 - 01/2016
1	Secondary Prevention 01/2022
1	Percutaneous Coronary Intervention 01/2022